This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.
Research
Latest papers
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.
bioRxiv : the preprint server for biology · 2026
Inhibition of PAK2 in endothelial cells suppresses tumor angiogenesis and promotes immune sensitization through CXCL10.
Cell reports · 2026
IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation.
Cancers · 2023
Latest funding
- $856,800
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
CIHR · 2023 · Nominated PI
- $100,000
Control of hematopoietic cell fate by LMO2
CIHR · 2016 · Nominated PI
- $928,869
Characterization of the Cdc37/Hsp90 complex as a regulator of the Notch ligands
CIHR · 2016 · Co-investigator
18 publications.
A Chemical-Genetic Interaction Matrix Reveals Drug Mechanism and Genetic Architecture.
Coulombe-Huntington J, Bertomeu T, Huard C, Chatr-Aryamontri A, St-Cyr DJ, Sánchez-Osuna M, Papadopoli D, Normandin K, Paydar M, McLaughlan S, St-Denis C, Zhang L, Say H, Palou R, Stark C, Breitkreutz BJ, van der Sloot AM, Manohar S, Lavoie H, Borden KLB, Raught B, D'Amours D, Sicheri F, Verreault A, Mader S, Meloche S, Therrien M, Thibault P, Wilhelm B, Dirks PB, Aitchison JD, Patton E, King RW, Roux PP, Sauvageau G, Hoang T, Marinier A, Harrington L, Kwok B, Archambault V, Topisirovic I, Tyers M
Inhibition of PAK2 in endothelial cells suppresses tumor angiogenesis and promotes immune sensitization through CXCL10.
Corriveau J, Monot P, Delisle C, Goyette MA, Gasse C, El Bakkouri Y, Hoang T, Côté JF, Gratton JP
IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation.
Nandi M, Ghosh A, Akbari SA, Bobbala D, Boucher MJ, Menendez A, Hoang T, Ilangumaran S, Ramanathan S
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Tremblay M, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, Furudate K, Rojas-Sutterin S, Haman A, Gareau Y, Marinier A, Ma H, Harutyunyan K, Daher M, Garcia LM, Al-Atrash G, Piya S, Ruvolo V, Yang W, Shanmugavelandy SS, Feng N, Gay J, Du D, Yang JJ, Hoff FW, Kaminski M, Tomczak K, Eric Davis R, Herranz D, Ferrando A, Jabbour EJ, Emilia Di Francesco M, Teachey DT, Horton TM, Kornblau S, Rezvani K, Sauvageau G, Gagea M, Andreeff M, Takahashi K, Marszalek JR, Lorenzi PL, Yu J, Tiziani S, Hoang T, Konopleva M
Author Correction: Sonic hedgehog accelerates DNA replication to cause replication stress promoting cancer initiation in medulloblastoma.
Tamayo-Orrego L, Gallo D, Racicot F, Bemmo A, Mohan S, Ho B, Salameh S, Hoang T, Jackson AP, Brown GW, Charron F
Sonic hedgehog accelerates DNA replication to cause replication stress promoting cancer initiation in medulloblastoma.
Tamayo-Orrego L, Gallo D, Racicot F, Bemmo A, Mohan S, Ho B, Salameh S, Hoang T, Jackson AP, Brown GW, Charron F
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.
Da Costa EM, Armaos G, McInnes G, Beaudry A, Moquin-Beaudry G, Bertrand-Lehouillier V, Caron M, Richer C, St-Onge P, Johnson JR, Krogan N, Sai Y, Downey M, Rafei M, Boileau M, Eppert K, Flores-Díaz E, Haman A, Hoang T, Sinnett D, Beauséjour C, McGraw S, Raynal NJ
Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.
Chennupati V, Veiga DF, Maslowski KM, Andina N, Tardivel A, Yu EC, Stilinovic M, Simillion C, Duchosal MA, Quadroni M, Roberts I, Sankaran VG, MacDonald HR, Fasel N, Angelillo-Scherrer A, Schneider P, Hoang T, Allam R
Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.
Zhang X, Lavoie G, Méant A, Aubert L, Cargnello M, Haman A, Hoang T, Roux PP
The LMO2 oncogene regulates DNA replication in hematopoietic cells.
Sincennes MC, Humbert M, Grondin B, Lisi V, Veiga DF, Haman A, Cazaux C, Mashtalir N, Affar el B, Verreault A, Hoang T
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
Principal investigators: Hoang, Trang K; Perreault, Claude; Thibault, Pierre
Keywords: Chemogenomic Vulnerability; Immunopeptidome; Primary T-All Samples; T-Cell Acute Lymphoblastic Leukemia (T-All); Tumor Specific Antigen
Control of hematopoietic cell fate by LMO2
Principal investigators: Hoang, Trang K
Keywords: Genetic Collaboration; Knock-Out Mice; Leukemia; Lmo1 Oncogene; Lmo2 Oncogene; Pre-Leukemic Stem Cells; Scl/Tall; T-All; Thymocyte; Transgenic Mice
Characterization of the Cdc37/Hsp90 complex as a regulator of the Notch ligands
Principal investigators: Emery, Gregory
Keywords: Cancer; Cdc37; Cell Signalling; Chaperone; Delta; Leukemia; Notch Signalling; T-All
Dynamic variations in DNA-bound transcription complexes during erythroid differentiation
Principal investigators: Hoang, Trang
Modelling T cell leukemogenesis in mice
Principal investigators: Hoang, Trang K
Keywords: Flow Cytometry; Genetic Collaboration; Heb Transcription Factor; Leukemia; Lmo1 Oncogene; T-All; Thymocyte; Transgenic Mice
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Institut de recherche en immunologie et cancer
- Pharmacology
- Cellular and Molecular Medicine
- Immunologie-Biologie Cellulaire
- Biochimie et médecine moléculaire
- Chemistry
- Microbiologie et d'infectiologie
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Guy Sauvageau
Institut de recherche en immunologie et cancer
4 shared papers, latest 2026
Anne Marinier
Chemistry
2 shared papers, latest 2026
Alain Verreault
Institut de recherche en immunologie et cancer
2 shared papers, latest 2026
Damien D'Amours
Cellular and Molecular Medicine
1 shared papers, latest 2026
Ivan Topisirovic
Faculty
1 shared papers, latest 2026
Moutih Rafei
Physiology and Pharmacology
1 shared papers, latest 2019
Moutih Rafei
Microbiology
1 shared papers, latest 2019
Pierre Thibault
Faculty
1 shared papers, latest 2026
Sylvie Mader
Chemical Engineering
1 shared papers, latest 2026
Vincent Archambault
Biochimie et médecine moléculaire
1 shared papers, latest 2026
Brian Raught
Research Institute
1 shared papers, latest 2026
Kolja Eppert
Pediatrics
1 shared papers, latest 2019
Eric Lecuyer
Biochimie
1 shared papers, latest 2014
Sheela Ramanathan
Immunologie-Biologie Cellulaire
1 shared papers, latest 2023
Jean-Philippe Gratton
Pharmacology
1 shared papers, latest 2026
Subburaj Ilangumaran
Immunologie-Biologie Cellulaire
1 shared papers, latest 2023
Ivan Topisirovic
Lady Davis Institute for Medical Research
1 shared papers, latest 2026
Michael Downey
Cellular and Molecular Medicine
1 shared papers, latest 2019
Alfredo Menendez
Microbiologie et d'infectiologie
1 shared papers, latest 2023
Marc Therrien
Faculty
1 shared papers, latest 2026
Frank Sicheri
Lunenfeld-Tanenbaum Research Institute
1 shared papers, latest 2026
Sylvain Meloche
Institut de recherche en immunologie et cancer
1 shared papers, latest 2026
Sylvie Mader
Biochimie et médecine moléculaire
1 shared papers, latest 2026
Claude Perreault
Institut de recherche en immunologie et cancer
1 shared papers, latest 2010
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.